Skip to main content

$0.002 0.001 (50.00%)

High

$0.00

Low

$0.00

Trades

39

Turnover

$1,563

Volume

1,562,054
30 June 2023 at 3:44pm
Register to track TD1 and receive email alerts.

TALi Product Clinical & International Update & 4C

StockBot

416,823 posts

TD1 released this announcement to the ASX on 31 January 2022, 18:32. The announcement is marked as price sensitive, and is 10 page(s) in length and 487.6kb in size.

You can view all announcements from TD1 and see how they appear on a price chart on the announcements page.

At the date of this announcement, TD1 was 0.057% short sold according to ASIC data. It was ranked the 514th most shorted stock on the ASX. It remains ranked 593rd as of the latest reported data (13 December 2022).

Other Recent Announcements from TD1
Strategic Review and Update on CEO Arrangements 16 June 2023, 9:07
Quarterly Activities/Appendix 4C Cash Flow Report 27 April 2023, 14:53
Change in substantial holding 3 April 2023, 10:29
TALi Product Clinical & International Update & 4C 31 January 2022, 18:32
Notification regarding unquoted securities - TD1 11 January 2022, 15:00
Initial Director's Interest Notice 15 December 2021, 17:44
Director Appointment/Resignation 15 December 2021, 9:45
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track TD1 and receive email alerts.